BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 9026954)

  • 1. [The drug therapy of chronic venous insufficiency (a trial of the clinical use of the preparation Detralex)].
    Iablokov EG; Bogachev VIu; Domoradskaia AI
    Ter Arkh; 1996; 68(10):80-1. PubMed ID: 9026954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advantage of a micronized flavonoidic fraction (Daflon 500 mg) in comparison with a nonmicronized diosmin.
    Amato C
    Angiology; 1994 Jun; 45(6 Pt 2):531-6. PubMed ID: 8203783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled studies of Daflon 500 mg in chronic venous insufficiency.
    Geroulakos G; Nicolaides AN
    Angiology; 1994 Jun; 45(6 Pt 2):549-53. PubMed ID: 8203786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Edema as a measure for severity of chronic venous insufficiency and efficacy of its treatment].
    Sapelkin SV
    Angiol Sosud Khir; 2008; 14(3):79-81. PubMed ID: 19791434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The principles of action and use of phlebotropic agents].
    Kharkevich DA
    Klin Med (Mosk); 2004; 82(11):4-10. PubMed ID: 15656390
    [No Abstract]   [Full Text] [Related]  

  • 6. [Risk factors of chronic venous insufficiency of the lower extremities and possibilities of its medication in therapeutic practice].
    Oganov RG; Savel'ev VS; Shal'nova SA; Kirienko AI; Zolotukhin IA
    Ter Arkh; 2006; 78(4):68-72. PubMed ID: 16821427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double blind study of the pharmacodynamic and clinical activities of 5682 SE in venous insufficiency. Advantages of the new micronized form.
    Cospite M; Dominici A
    Int Angiol; 1989; 8(4 Suppl):61-5. PubMed ID: 2698903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is There a Difference in the Clinical Efficacy of Diosmin and Micronized Purified Flavonoid Fraction for the Treatment of Chronic Venous Disorders? Review of Available Evidence.
    Cazaubon M; Benigni JP; Steinbruch M; Jabbour V; Gouhier-Kodas C
    Vasc Health Risk Manag; 2021; 17():591-600. PubMed ID: 34556990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Pycnogenol on the Healing of Venous Ulcers.
    Toledo RR; Santos MERC; Schnaider TB
    Ann Vasc Surg; 2017 Jan; 38():212-219. PubMed ID: 27521821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Microcirculation end effect of detralex in patients with chronic venous insufficiency of the lower extremities].
    Sirotin BZ; Zhmerenetskĭ KV
    Angiol Sosud Khir; 2003; 9(3):60-5. PubMed ID: 14657934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flavonoids. A review of the pharmacology and therapeutic efficacy of Daflon 500 mg in patients with chronic venous insufficiency and related disorders.
    Struckmann JR; Nicolaides AN
    Angiology; 1994 Jun; 45(6):419-28. PubMed ID: 8203767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Certain aspects of pathogenesis of hemorheological and trophic disturbances and their pharmacological correction in patients with chronic venous insufficiency].
    Aliev SA; Ibishov KG; Aliev ES
    Vestn Khir Im I I Grek; 2008; 167(2):39-43. PubMed ID: 18522184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. At the crossroads of venous insufficiency and hemorrhoidal disease: Daflon 500 mg--repercussions of venous insufficiency on everyday life.
    Launois R
    Angiology; 1994 Jun; 45(6 Pt 2):495-504. PubMed ID: 8203779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The chronobiology and clinical efficacy of Daflon in the treatment of chronic venous insufficiency].
    Menyhelyi G; Acsády G; Hetényi A; Dubeaux D; Radó G
    Ter Arkh; 1997; 69(4):46-8. PubMed ID: 9213959
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety and security of Daflon 500 mg in venous insufficiency and in hemorrhoidal disease.
    Meyer OC
    Angiology; 1994 Jun; 45(6 Pt 2):579-84. PubMed ID: 8203791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. At the Crossroads of Venous Insufficiency and Hemorrhoidal Disease: Daflon 500 mg. Proceedings of a symposium. Vienna, Austria, January 31, 1992.
    Angiology; 1994 Jun; 45(6 Pt 2):493-584. PubMed ID: 7911285
    [No Abstract]   [Full Text] [Related]  

  • 17. Laser Doppler and transcutaneous oximetry: modern investigations to assess drug efficacy in chronic venous insufficiency.
    Belcaro G; Cesarone MR; de Sanctis MT; Incandela L; Laurora G; Février B; Wargon C; De Gregoris P
    Int J Microcirc Clin Exp; 1995; 15 Suppl 1():45-9. PubMed ID: 8748889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Techniques used to evaluate the cutaneous microcirculation: application of photoplethysmography to the assessment of a phlebotropic agent in the treatment of leg ulcers.
    Guillot B
    Angiology; 1994 Jun; 45(6 Pt 2):542-8. PubMed ID: 8203785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of semisynthetic diosmin in chronic venous insufficiency].
    Coget JM; Merlen JF
    LARC Med; 1982; 2(7):609-10. PubMed ID: 7167035
    [No Abstract]   [Full Text] [Related]  

  • 20. [Semisynthetic Diosmin (Phlebodia 600) for therapy of lower limb chronic venous insufficiency].
    Kirienko AI; Bogachev VIu; Zolotukhin IA; Golovanova OV
    Angiol Sosud Khir; 2006; 12(2):73-5. PubMed ID: 17053765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.